Invesque Inc. Completes Private Placement of Preferred Shares to Funds Managed by Magnetar Financial LLC
Goodmans LLP represented Invesque Inc. (Invesque) in its private placement of preferred shares in three tranches for proceeds of US$71.5 million to certain funds managed by Magnetar Financial LLC (Magnetar). The first tranche closed on December 22, 2017 and resulted in the issuance of 2,802,009 Class A Series 1 Convertible Preferred Shares to Magnetar at a price of US$9.4575 per share for aggregate gross proceeds of US$26.5 million. The second tranche closed on February 9, 2018 which resulted in the issuance of 3,172,086 Class A Series 2 Convertible Preferred Shares for aggregate gross proceeds of US$30 million. The third and final tranche closed on March 29, 2018 which resulted in the issuance of 1,586,042 Class A Series 3, convertible preferred shares for aggregate gross proceeds of US$15 million. Total proceeds of the private placement totalled US$71.5 million. The proceeds from the investment will be used for the repayment of debt, for general working capital purposes and to fund future acquisitions.
Expertise
Featured Work
-
Capital Markets
CIBC Capital leads C$400 million Oxford Properties Group Trust debt offering
Goodmans LLP acted for CIBC Capital Markets, as Lead Left Joint Bookrunner, and the agents in connection with a C$400 million senior unsecured notes offering for Oxford Properties Group Trust (“OPGT… -
Banking and Finance
Vital Infrastructure Property Trust completes C$300 million senior unsecured debentures offering
Goodmans LLP acted for Vital Infrastructure Property Trust in connection with its private placement offering of C$300 million aggregate principal amount of 4.865% Series C senior unsecured debentures… -
Capital Markets
Apotex Health Corp. closes $1.25 billion inaugural senior unsecured notes offering
Goodmans LLP acted for Apotex Health Corp. in connection with its private placement offering of $1.25 billion aggregate principal amount of senior unsecured notes… -
Entertainment
WildBrain announces a C$20 million substantial issuer bid
Goodmans LLP is acting for WildBrain Ltd. in connection with its substantial issuer bid to purchase, for cancellation, a number of common shares of the company for an aggregate purchase price not… -
Capital Markets
Apotex Health Corp. completes upsized $850 million bought deal secondary offering
Goodmans LLP acted for Apotex Health Corp. in connection with the closing of the upsized bought deal secondary offering of its common shares by an affiliate of SK Capital Partners, API Investment LP… -
Mergers and Acquisitions
Onex Partners and co-investors acquire AirSprint
Goodmans LLP acted as M&A legal counsel to Onex Partners in connection with the acquisition of AirSprint Inc. by Onex and its co-investors…